Cleared Traditional

K042504 - CATHY STERILE DISPOSABLE I.V. CANNULA WITH CATHETER (FDA 510(k) Clearance)

Jan 2006
Decision
491d
Days
Class 2
Risk

K042504 is an FDA 510(k) clearance for the CATHY STERILE DISPOSABLE I.V. CANNULA WITH CATHETER. This device is classified as a Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days (Class II - Special Controls, product code FOZ).

Submitted by Myco Medical Supplies, Inc. (Cary, US). The FDA issued a Cleared decision on January 19, 2006, 491 days after receiving the submission on September 15, 2004.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5200.

Submission Details

510(k) Number K042504 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 15, 2004
Decision Date January 19, 2006
Days to Decision 491 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement

Device Classification

Product Code FOZ - Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5200

Similar Devices - FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

All 14
BD Saf-T-Intima™ Subcutaneous Catheter System
K251422 · Becton Dickinson Infusion Therapy Systems, Inc. · Oct 2025
BD Nexiva™ Closed IV Catheter System
K243403 · Becton Dickinson Infusion Therapy Systems, Inc. · Jul 2025
BD Cathena™ Safety IV Catheter
K251155 · Becton Dickinson Infusion Therapy Systems, Inc. · Jul 2025
BD Insyte™ Autoguard™ Shielded IV Catheter, BD Insyte™ Autoguard™ BC Shielded IV Catheter and BD Insyte™ Autoguard™ BC Pro Shielded IV Catheter
K251654 · Becton Dickinson Infusion Therapy Systems, Inc. · Jun 2025
BD Nexiva™ Diffusics™ Closed IV Catheter System and BD Nexiva™ Diffusics™ Closed IV Catheter System with BD MaxZero™ Needle-free Connector
K250682 · Becton Dickinson Infusion Therapy Systems, Inc. · Jun 2025
Introcan Safety® 2 IV Catheter
K241845 · B.Braun Medical, Inc. · Jul 2024